For research use only. Not for therapeutic Use.
Glipizide-d11 is a deuterated version of glipizide, a widely used oral hypoglycemic agent for treating type 2 diabetes. In this compound, eleven hydrogen atoms are replaced by deuterium, enhancing its stability and making it a valuable tool in pharmacokinetic and metabolic research. The deuterium labeling allows for precise tracking in studies using NMR spectroscopy and mass spectrometry, enabling detailed analysis of glipizide’s absorption, distribution, metabolism, and excretion. Glipizide-d11 is crucial for researchers focused on developing improved diabetes treatments and understanding the drug’s interaction with biological systems, offering greater accuracy and reliability in experimental results.
Catalog Number | R005227 |
CAS Number | 1189426-07-0 |
Synonyms | N-[2-[4[[[(Cyclohexylamino-d11)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methylpyrazinecarboxamide; 1-(Cyclohexyl-d11)-3-[[p-[2-(5-methylpyrazinecarboxamido)?ethyl]phenyl]sulfonyl]urea; Aldiab-d11; Digrin-d11; Dipazide-d11; Glibenese-d11; Glibetin-d11; |
Molecular Formula | C21H27N5O4S |
Purity | ≥95% |
Target | Potassium Channel |
Storage | Store at -20°C |
IUPAC Name | 5-methyl-N-[2-[4-[(1,2,2,3,3,4,4,5,5,6,6-undecadeuteriocyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]pyrazine-2-carboxamide |
InChI | InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)/i2D2,3D2,4D2,5D2,6D2,17D |
InChIKey | ZJJXGWJIGJFDTL-KVEFGMAKSA-N |
SMILES | 2H]C1(C(C(C(C(C1([2H])[2H])([2H])[2H])([2H])NC(=O)NS(=O)(=O)C2=CC=C(C=C2)CCNC(=O)C3=NC=C(N=C3)C)([2H])[2H])([2H])[2H])[2H] |